BLOCKStrain Technology Corp., creator of the first Blockchain-secured, fully-integrated IP tracking platform for the cannabis industry, today announced that Harvest One Cannabis Inc., a Canadian licensed producer of medical cannabis, will employ BLOCKStrain's proprietary genome tracking software to collect and register its cannabis plant DNA and strains. By incorporating BLOCKStrain's cannabis strain authenticity and tracking platform - the Master Genome Strain and Clone Registration Program - into its sales program, Harvest One is expected to be able to confirm its medical cannabis strains are as labelled, providing its consumers with increased transparency and confidence about its products. Upon completion of the collection and registration of its strains, an initial 30 Harvest One products will carry BLOCKStrain's Seal of Authenticity, guaranteeing their origin and providing quality assurance.
"This agreement with Harvest One is a testament to the growing traction of our proprietary genome-to-sale software, which we expect to increase as more companies recognize the inherent and significant value in protecting the genetics and IP of their various strains," said BLOCKStrain's Chief Executive Officer, Robert Galarza. "We believe our unique technology will enable Harvest One to guarantee its strains and provide consumers with unparalleled assuredness about the products they purchase. This is of particular importance for medical cannabis when patients with specific conditions are relying on products to be of consistent quality and provide consistent results."
